Stay Ahead of the Game With CVS Health (CVS) Q2 Earnings: Wall Street's Insights on Key Metrics

Wall Street expects CVS Health (CVS) to report Q2 earnings of $1.87 per share, up 3.3% year over year. Revenues are forecast at $100.18 billion, a 1.3% increase versus the year-ago quarter. The consensus EPS estimate has been revised 0.4% higher over the last 30 days, reflecting updated expectations from analysts covering the stock. The article argues that tracking revisions to estimates can help gauge potential investor reaction and then outlines projected key metrics CVS will likely report. Analysts expect Revenue- Health Care Benefits at $35.70 billion (-1.6%), Net revenue for the Health Services segment at $48.28 billion (+3.9%) and Revenue for the Pharmacy & Consumer Wellness segment at $33.58 billion. It also cites medical membership and Medical benefit ratio targets, including Medical membership - Total at 25.97 million and an MBR estimate of 89.3%.